Melanoma Uveal melanoma Acral lentiginous melanoma Amelanotic melanoma Equine melanoma Desmoplastic melanoma Epigenetics and melanoma Superficial spreading melanoma Nodular melanoma Melanoma Research Small-cell melanoma Lentigo maligna melanoma Pigment Cell & Melanoma Research Melanoma with features of a Spitz nevus Limnaecia melanoma Mucosal melanoma Nevoid melanoma Animal-type melanoma Vaginal melanoma Polypoid melanoma Melanoma Institute Australia Melanoma inhibitory activity Dysplastic nevus syndrome AIM at Melanoma Foundation B16 Melanoma Lentigo maligna Aniuta melanoma Ciliary body melanoma Skin cancer Nevi and melanomas Melanoma-associated leukoderma CDKN2A Breslow's depth …

HMB-45 James A. Schlipmann Melanoma Cancer Foundation Spitz nevus Australian Melanoma Research Foundation Melanoma antigen family a, 8 Dysplastic nevus CD146 Clear cell sarcoma CSPG4 Melanoma-associated antigen GPNMB Benign melanocytic nevus Melanocytic nevus Choroidal nevus Mensacarcin Georgina Long Diana Merriweather Ashby Skin cancer in Australia Cancer vaccine CP-GEP Wallace H. Clark Jr. Samra Turajlic Richard

Scolyer MDA5 Meenhard Herlyn DecisionDx-UM Skin cancer in horses AIM1 Vemurafenib Ze'ev Ronai María Soengas Elizabeth Patton MLANA Jessamy Tiffen TANGO1/MIA3 Ashani Weeraratna Clark's level Gp100:209-217(210M) J. William Harbour Richard Marais Melafind PHEC-66 Encorafenib Cysteinyldopa Trametinib Vulvar cancer Thomas B. Fitzpatrick SCIB1 Microphthalmia-associated transcription factor NCI-60 Colin Bloomfield Melanotransferrin Binimetinib Viralytics MAGEA3 ABCB5 MEK inhibitor Clare Oliver Kelly M. McMasters CancerVax Margaret A. Tucker SPRY4-IT1 Slip-Slop-Slap Fotemustine MAGEA1 Gray horse John M. Edwards Dabrafenib Herbert Snow Blue nevus BIRC7 Nivolumab Glembatumumab vedotin Debra Black Nivolumab/relatlimab Whitlow Bempegaldes